ATP-α3 was upregulated in colon cancer; however, the role of FXYD6 in modulating the expression of ATP-α3 and regulating cell autophagy and apoptosis leading to drug sensitivity needs to be investigated in the future. Here, FXYD6 is linked to colonic neoplasm.